Back

Engineered pluripotent stem cell-derived cardiomyocytes prevent serious engraftment-related arrhythmia in nonhuman primates

31 August 2025 (14:05 - 14:15)
Organised by: Logo
Congress Presentation Part of: Molecular and cellular drivers of arrhythmia Gene Therapy, Cell Therapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Associate Professor Kenta Nakamura

University of Washington, Seattle (United States of America)

4 More presentations in this session

Presentation thumbnail
Investigation of a novel SLC4A3 variant causing short QT Syndrome: functional and pharmacological evaluation in a knock-in zebrafish model
Ms M. Zhu (Suita, JP)
Abstract Slides Video
Presentation thumbnail
SGK1 inhibition shortens action potential duration and exerts anti-arrhythmic effects in LQT3 mice and LQT2 rabbits by reducing enhanced late sodium current
Doctor S. Casini (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
DECA11 selectively increases human INa and IK1 and is antiarrhythmic in a mouse model of heart failure
Professor R. Caballero (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Atrial electrophysiological disturbances caused by disruption of the RBM20 splicing factor
Mr L. Weirauch (Heidelberg, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular and cellular drivers of arrhythmia
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 14:05 CET
You may be interested in
thumbnail
Congress Presentation
Quiescent-yet-excitable pluripotent stem cell-derived cardiomyocytes engraft without fatal arrhythmias in minipig and primates
thumbnail
Congress Session
Molecular and cellular drivers of arrhythmia
thumbnail
Congress Session
Late-Breaking Basic & Translational Science

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources